David Einhorn's Greenlight Capital has closed its position in insurer Brighthouse Financial following a sale agreement, detailing the move in its latest investor letter. The hedge fund reported solid quarterly returns but continues to trail the broader market.
Titan Wealth Holdings has agreed to acquire Plymouth's Sound Financial Management, a move set to add approximately £600m in advised assets and bolster the group's regional presence in England's growing southwest market.
Indian e-commerce challenger Meesho reported a significant widening of its quarterly net loss to ₹4.91 billion, as a 44% surge in expenses outpaced strong revenue growth, marking a costly start to its life as a public company.
Shares of Axos Financial (AX) have surged, closing at $94.64 and delivering strong returns over multiple timeframes. This momentum has reignited the debate among investors: is the stock still undervalued against its fair value estimate of $100.50, or has the market already priced in its future growth?
Personal finance authority Suze Orman cuts through the noise with six straightforward, often challenging, principles for achieving financial security. From emergency funds to retirement planning, her no-nonsense guidance demands attention.
While speculative stories often captivate the market, Waterstone Financial (NASDAQ:WSBF) stands out with consistent profitability and disciplined leadership—traits gaining attention as investors prioritize fundamentals.
Multiple executives and board members at AmeriServ Financial have been buying shares in the company over the past year, a move often interpreted as a bullish signal for the regional bank's prospects.
Axos Financial's recent acquisition of Verdant Commercial Capital and its deepening investment in artificial intelligence are translating into tangible financial gains, with robust loan growth and surging share prices highlighting the digital bank's evolving strategy.
Corebridge Financial (CRBG) has launched a novel index annuity linked to the Invesco New Economy Index, offering exposure to tech themes and Bitcoin. The move comes as analysts debate whether the company's current share price fully reflects its growth potential amid mixed recent performance.
In a volatile market, certain low-priced Asian stocks are drawing attention not just for their valuation, but for underlying financial strength. We examine three such companies—from healthcare in New Zealand to property services in Greater China—that defy the typical 'penny stock' stereotype with solid fundamentals.
Axos Financial Inc. (AX) reported robust second-quarter earnings for fiscal 2026, highlighted by a 23.3% surge in earnings per share and significant loan portfolio expansion, even as it manages industry-wide margin pressures and rising operational costs.
LPL Financial Holdings Inc. (LPLA) reported robust fourth-quarter results, reaching a milestone $2.4 trillion in advisory and brokerage assets. Adjusted earnings per share grew 23%, driven by strategic execution and the integration of Commonwealth Financial.
Ally Financial shares have experienced significant price swings, leaving investors to question if the current level around $42.96 presents a buying opportunity. While short-term performance has been mixed, our analysis suggests the stock may be trading below its intrinsic value.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
LPL Financial reported record quarterly and annual earnings, driven by robust organic growth and strategic acquisitions. Executives detailed progress on integrating Commonwealth Financial Network and provided updated guidance, signaling confidence in sustained momentum despite market headwinds.
For the first time since its aggressive accumulation began, MicroStrategy's massive Bitcoin treasury is valued below its average purchase price, incurring over $900 million in unrealized losses. The milestone tests the resilience of CEO Michael Saylor's leveraged conviction play as analysts debate the company's financial fortitude and Bitcoin's near-term path.
Investors in lighting specialist FW Thorpe have seen a negative total shareholder return of 25% since 2021, starkly underperforming the broader market's gains. Despite steady revenue growth, the share price decline highlights a disconnect with company fundamentals.
Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.
While Italtile's stock saw an 11% bump last month, a look at the past five years reveals a sobering picture for long-term investors, with total shareholder returns deep in negative territory even as company earnings grew.
Japan's financial giant Nomura Holdings is scaling back risk at its digital asset unit following Q3 losses, a strategic pullback that mirrors wider pain across the crypto treasury sector as Bitcoin struggles to hold key levels.
